DANIAH SHABAN: Open Payments
NPI 1790295277 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,885 in 54 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,885
Food & beverage: $1,793Education: $92
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 6 | $419 |
| Galderma Laboratories, L.P. | 8 | $229 |
| UCB, Inc. | 3 | $175 |
| ABBVIE INC. | 3 | $158 |
| Lilly USA, LLC | 3 | $155 |
| Incyte Corporation | 1 | $122 |
| GENZYME CORPORATION | 3 | $113 |
| PFIZER INC. | 5 | $100 |
| LEO Pharma Inc. | 1 | $81 |
| Arcutis Biotherapeutics, Inc. | 3 | $59 |
Products named: DUPIXENT, NEMLUVIO, Bimzelx, SKYRIZI, Opzelura, EBGLYSS, CIBINQO, ANZUPGO.
Industry payments across AZ — which companies pay providers there.
